Highlights of the Annual Meeting
A dynamic forum for best practice sharing within industry, CRO’s, academics and regulators
Joint Sessions organized by representatives from SPS, CSPT, and JSPS
Sessions on some of the hottest topics in safety pharmacology related research
6 CE Courses taught by experts in the field
Plenary Keynote Speakers by a key opinion leaders
Exhibit hall offering access to industry vendors
Poster sessions featuring cutting-edge research
Networking opportunities with a global community of scientists from regulatory, industry, and academia
Award opportunities to bring together Student and Jr. Investigators with seasoned scientists, while sharing their research
Exhibitor Sponsored Sessions by leading technology and service providers showcasing their new offerings and research
The Joint Meeting will unite 500+ industry professionals for four days of intensive best practice sharing, education and networking.
Exhibitors interact with high-level, influential decision makers who attend SPS to discover innovative, emerging technologies and form industry partnerships.
Two complimentary full conference registrations (per 100 square feet), which entitle the exhibitor to participate in all scientific sessions and social functions;
Company listing and exhibit location published in the Society's Annual Meeting Program provided to all meeting attendees;
All networking functions including breaks, lunches, and poster sessions occur within the exhibit space;
A variety of ways to communicate and connect with attendees through exclusive advertising and marketing opportunities.
Safety Pharmacology Society is a nonprofit organization that promotes knowledge, development, application, and training in Safety Pharmacology - a distinct scientific discipline that integrates the best practices of pharmacology, physiology and toxicology. The objective of Safety Pharmacology studies is to further the discovery, development and safe use of biologically active chemical entities by the identification, monitoring and characterization of potentially undesirable pharmacodynamic activities in nonclinical studies. The Safety Pharmacology Society also supports the human safety of drugs and biologicals by fostering scientific research, education, and dissemination of scientific information through meetings and other scientific interactions.